Page 109 - Screening for Cervical Cancer: Systematic Evidence Review

Appendix C. Evidence Tables

Evidence Table 1A. Screening Among Older Women (cont'd)

Screening Outcomes & Quality
Participants Program Measures Relevant Results Considerations
N = 312,858 Primary AGE: Denom=2
women with Outcome = First Screening Cycle Attrition=0
407,246 Paps histologic Rates* of histology-proven diagnoses Indications=1
diagnoses of CIN 2 CIN 3/CIS Interval=0
Services CIN 2,3, CIS Invasive Age=2
intended for and invasive < 30 11.0 7.9 0.1 Relevance=2
30-39 4.9 6.7 0.4
low-income cancer 40-49 2.0 3.2 0.5 Standard=0
women 50-64 0.9 1.7 0.6 Score=7
(all cases with ≥ 65 0.5 1.4 0.3
Age histology from Grade=Fair
40-49 25.2% CIN 1, up Second Screening Cycle
50-64 24.9% reported) Rates* of histology-proven diagnoses
≥ 65 7.6% CIN 2 CIN 3/CIS Invasive
Secondary < 30 7.6 4.2 0.1
30-39 3.8 4.1 0.4
Black, non-Hisp outcome = 40-49 1.7 1.3 0.2
10.3% cytology 50-64 0.7 1.2 0.1
Hisp 21.2% findings ≥ 65 0.8 0.7 0.0
Asian 2.3%
AmInd 10.4% * Rates = diagnoses per 1000 Pap
smears
First test Subsequent
Age % Abnormal %Abnormal
< 30 8.2 7.4
30-39 4.3 4.2
40-49 2.3 2.3
50-64 1.4 1.5
≥ 65 1.0 1.0

C-15